CSCIED

期刊目次

加入编委

期刊订阅

添加您的邮件地址以接收即将发行期刊数据:

Open Access Article

International Journal of Clinical Research. 2023; 7: (4) ; 140-142 ; DOI: 10.12208/j.ijcr.20230190.

Effect of salmeterol and fluticasone in the treatment of COPD
沙美特罗替卡松治疗慢阻肺的效果

作者: 王磊 *

江苏省锡山人民医院东亭分院 江苏无锡

*通讯作者: 王磊,单位:江苏省锡山人民医院东亭分院 江苏无锡;

发布时间: 2023-04-13 总浏览量: 297

摘要

目的 回顾分析院内慢阻肺患者中实施沙美特罗替卡松的作用。方法 纳入时间为2022年1月到2023年1月,将该时间段院内慢阻肺患者进行研究讨论,包括62例患者,通过随机分配法安排为对照组(31例实施常规治疗措施)、观察组(31例利用沙美特罗替卡松治疗),对相关数据信息进行收集与整理,最后利用统计学进行处理。结果 由统计学系统对治疗结果数据进行处理,结果P值不足0.05,观察组肺功能指标方面、生活质量方面满意度方面等各项数据信息更佳。结论 使用沙美特罗替卡松有助于慢阻肺治疗工作顺利开展,可对患者症状改善产生积极影响,降低患者肺功能指标异常波动风险,有利于改善患者生活质量状况,可为患者提供更为满意的治疗方案,在提升治疗效果方面有着重要意义。

关键词: 沙美特罗替卡松;慢阻肺;肺功能;生活质量

Abstract

Objective: To review and analyze the effect of salmeterol and fluticasone in patients with COPD in hospital.
Methods: From January 2022 to January 2023, the patients with COPD in the hospital were studied and discussed, including 62 patients. They were randomly assigned to the control group (31 patients were treated with routine treatment) and the observation group (31 patients were treated with salmeterol and ticasone), and the relevant data were collected and sorted, and finally processed by statistics.
Results: TThe treatment result data were processed by the statistical system, and the result P value was less than 0.05. The observation group had better data information on lung function indicators, quality of life, satisfaction, and other aspects.
Conclusion  : The use of salmeterol and fluticasone can contribute to the smooth development of chronic obstructive pulmonary disease treatment, have a positive impact on the improvement of patients' symptoms, reduce the risk of abnormal fluctuations in lung function indicators, improve the quality of life of patients, provide patients with a more satisfactory treatment plan, and have important significance in improving the treatment effect.

Key words: Salmeterol and fluticasone; Chronic obstructive pulmonary disease; Lung function; Quality of life

参考文献 References

[1] 穆喜泉. 沙美特罗氟替卡松联合噻托溴铵治疗慢阻肺临床效果分析[J]. 系统医学,2022,7(11):60-63.

[2] 赵红运. 噻托溴铵与沙美特罗替卡松在慢阻肺急性加重期治疗中的应用[J]. 中外女性健康研究,2022,7(22): 82-83,128.

[3] 苏新根,蓝慧平,戴千金. 沙美特罗替卡松气雾剂在慢阻肺呼吸衰竭患者中的应用效果[J]. 中外医学研究, 2022, 20(32):111-114. 

[4] 卢翠英,黎碧云,陈玲玲,等. 噻托溴铵联合沙美特罗替卡松治疗慢阻肺的疗效分析及评价[J]. 海峡药学, 2022, 34(6):118-120. 

[5] 王晓青. 疏风解毒胶囊联合沙美特罗替卡松对慢阻肺急性加重期患者血气指标及呼吸力学的影响[J]. 实用中西医结合临床,2021,21(16):15-16. 

[6] 王志红. 布地奈德福莫特罗、沙美特罗替卡松吸入治疗慢阻肺的作用及安全性分析[J]. 养生保健指南,2021,9(41):31-32. 

[7] 王振虎. 分析噻托溴铵联合沙美特罗替卡松治疗慢性阻塞性肺疾病(慢阻肺)急性加重期的疗效[J]. 健康必读,2021,12(22):65. 

[8] 程丽. 探讨慢阻肺患者采取沙美特罗替卡松+噻托溴铵联合治疗的临床效果[J]. 世界最新医学信息文摘(连续型电子期刊),2021,21(22):137-138,140. 

[9] 张新虹. 茶碱缓释片联合沙美特罗替卡松对慢阻肺稳定期患者的治疗研究[J]. 四川解剖学杂志,2021,29(4): 63-64,87.  

[10] 王丹. 沙美特罗替卡松配合BIPAP呼吸机治疗慢阻肺合并Ⅱ型呼吸衰竭的效果分析[J]. 当代医药论丛, 2022, 20(19):113-115.

引用本文

王磊, 沙美特罗替卡松治疗慢阻肺的效果[J]. 国际临床研究杂志, 2023; 7: (4) : 140-142.